Genitourinary Radiation Oncologist — Academic Leader in MRI-Guided Care

NYU Langone; New York (NY); On-site; USD 350,000 - 600,000; Full time

Job summary

NYU Langone Health's Radiation Oncology department invites a board-certified or board-eligible Radiation Oncologist with Genitourinary (GU) malignancies expertise to join our faculty. The position focuses on prostate, bladder, kidney, penile, and testicular cancers through innovation, collaboration, and academic excellence.

This nationally recognized program offers access to state-of-the-art technology and robust research infrastructure, with a collaborative GU disease management team, tumor

Qualifications

• MD, DO, or equivalent medical degree.
• Completion of an accredited Radiation Oncology residency.
• Board-certified or board-eligible in Radiation Oncology.
• Eligibility for NY medical licensure.
• Commitment to multidisciplinary cancer care.

Responsibilities

• Deliver evidence-based radiation oncology care for GU malignancies.
• Develop and expand the GU radiation oncology program.
• Lead or collaborate in clinical, translational, outcomes, and health services research.
• Support clinical trial enrollment and protocol development.
• Teach and mentor medical students, residents, fellows, and junior faculty.
• Collaborate across multiple clinical sites and regional cancer centers; contribute to departmental strategic initiatives, quality improvement efforts, and innovation programs.

Education

MD/DO or equivalent

Radiation Oncology residency

Board-certified or board-eligible in Radiation Oncology

Eligibility for medical licensure in New York State

Commitment to multidisciplinary cancer care

Job description

NYU Langone Health's Radiation Oncology department invites a board-certified or board-eligible Radiation Oncologist with Genitourinary (GU) malignancies expertise to join our faculty. The position focuses on prostate, bladder, kidney, penile, and testicular cancers through innovation, collaboration, and academic excellence.

This nationally recognized program offers access to state-of-the-art technology and robust research infrastructure, with a collaborative GU disease management team, tumor